Dr. lena Rivard, MD, MSc
Claim this profileMontreal Heart Institute
Studies Sarcoidosis
Studies Cardiac Sarcoidosis
6 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials lena Rivard, MD, MSc is currently running
Prednisone/Prednisolone Dosing
for Cardiac Sarcoidosis
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate combination will be as effective as standard dose Prednisone(or Prednisolone), and result in significantly better quality of life and less toxicity than standard dose Prednisone(or Prednisolone).
Recruiting4 awards Phase 35 criteria
Electrophysiology-Guided Care
for Left Bundle Branch Block After TAVI
The primary hypothesis of the proposed study is that an electrophysiology-based algorithmic approach is superior to standard clinical follow-up with 30-day monitoring in reducing the combined endpoint of syncope, hospitalization, and death in patients in patients with new of left bundle branch block following transcatheter aortic valve implantation (TAVI).
Recruiting1 award N/A3 criteria
More about lena Rivard, MD, MSc
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments lena Rivard, MD, MSc has experience with
- Rivaroxaban
- Catheter Ablation
- Antiarrythmic Drug Therapy
- Corticosteroid Therapy
- Implantation Of A Defibrillator
- Acetylsalicylic Acid
Breakdown of trials lena Rivard, MD, MSc has run
Sarcoidosis
Cardiac Sarcoidosis
Atrial Fibrillation
Rapid Heartbeat
Ventricular Tachycardia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does lena Rivard, MD, MSc specialize in?
lena Rivard, MD, MSc focuses on Sarcoidosis and Cardiac Sarcoidosis. In particular, much of their work with Sarcoidosis has involved treating patients, or patients who are undergoing treatment.
Is lena Rivard, MD, MSc currently recruiting for clinical trials?
Yes, lena Rivard, MD, MSc is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that lena Rivard, MD, MSc has studied deeply?
Yes, lena Rivard, MD, MSc has studied treatments such as Rivaroxaban, Catheter ablation, Antiarrythmic Drug Therapy.
What is the best way to schedule an appointment with lena Rivard, MD, MSc?
Apply for one of the trials that lena Rivard, MD, MSc is conducting.
What is the office address of lena Rivard, MD, MSc?
The office of lena Rivard, MD, MSc is located at: Montreal Heart Institute, Montreal, Quebec H1T 1C8 Canada. This is the address for their practice at the Montreal Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.